These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 7253793)
1. Differential effects of several dopamine uptake inhibitors and releasing agents on locomotor activity in normal and in reserpinized mice. Heikkila RE Life Sci; 1981 Apr; 28(17):1867-73. PubMed ID: 7253793 [No Abstract] [Full Text] [Related]
2. Relationship between the effects of dexamphetamine on locomotion and on striatal [3H]GBR 12783 binding in vivo. Vaugeois JM; Bonnet JJ; Costentin J Eur J Pharmacol; 1990 Mar; 178(2):221-7. PubMed ID: 2328762 [TBL] [Abstract][Full Text] [Related]
3. (-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release. Shimazu S; Takahata K; Katsuki H; Tsunekawa H; Tanigawa A; Yoneda F; Knoll J; Akaike A Eur J Pharmacol; 2001 Jun; 421(3):181-9. PubMed ID: 11516435 [TBL] [Abstract][Full Text] [Related]
4. Central actions of dopa and dopamine. Sourkes TL Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289 [No Abstract] [Full Text] [Related]
5. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors. Ferré S; Giménez-Llort L; Artigas F; Martínez E Eur J Pharmacol; 1994 Apr; 255(1-3):203-13. PubMed ID: 7913043 [TBL] [Abstract][Full Text] [Related]
6. Dopamine-independent and adenosine-dependent mechanisms involved in the effects of N-methyl-D-aspartate on motor activity in mice. Giménez-Llort L; Martínez E; Ferré S Eur J Pharmacol; 1995 Mar; 275(2):171-7. PubMed ID: 7796852 [TBL] [Abstract][Full Text] [Related]
7. Neostriatal dopamine uptake and reversal of age-related movement disorders with dopamine-uptake inhibitors. Altar CA; Marshall JF Ann N Y Acad Sci; 1988; 515():343-54. PubMed ID: 3364894 [No Abstract] [Full Text] [Related]
8. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736 [TBL] [Abstract][Full Text] [Related]
9. Differential behavioral and glial responses induced by dopaminergic mechanisms in the iNOS knockout mice. Issy AC; Nascimento GC; Abreu GHD; Tristão FS; Del-Bel E; Duarte T; Bortolanza M Behav Brain Res; 2018 Sep; 350():44-53. PubMed ID: 29751018 [TBL] [Abstract][Full Text] [Related]
10. The rise of body temperature induced by the stimulation of dopamine D1 receptors is increased in acutely reserpinized mice. Vasse M; Chagraoui A; Henry JP; Protais P Eur J Pharmacol; 1990 May; 181(1-2):23-33. PubMed ID: 1974857 [TBL] [Abstract][Full Text] [Related]
11. Axoplasmic transport of dopamine in nigro-striatal neurons. Fibiger HC; McGeer EG; Atmadja S J Neurochem; 1973 Aug; 21(2):373-85. PubMed ID: 4125072 [No Abstract] [Full Text] [Related]
12. Increased acoplasmic transport of H3-dopamine in nigro-neostriatal neurons after reserpine. Fibiger HC; McGeer EG Life Sci; 1973 Dec; 13(11):1565-71. PubMed ID: 4588712 [No Abstract] [Full Text] [Related]
13. Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission. Bredeloux P; Dubuc I; Costentin J Br J Pharmacol; 2007 Mar; 150(6):711-9. PubMed ID: 17293887 [TBL] [Abstract][Full Text] [Related]
14. Pre- and postsynaptic actions of a partial D2 receptor agonist in reserpinized young rats: longevity of agonistic effects. Farley CM; Baella SA; Wacan JJ; Crawford CA; McDougall SA Brain Res; 2006 Dec; 1124(1):37-44. PubMed ID: 17070785 [TBL] [Abstract][Full Text] [Related]
15. Effect of apomorphine on striatal synaptotagmin 7 mRNA levels in reserpinized rats. Pal R; Zivin M; Milutinovic A; Jernej B; Glavan G Neurosci Lett; 2007 Sep; 424(3):194-8. PubMed ID: 17719177 [TBL] [Abstract][Full Text] [Related]